Go Back   SuggestADoctor.com > Gian Mendez NOVARO MD
 


In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysis

Gian Mendez NOVARO MD
Florida, Weston
Cardiology
Registered Site MemberAddress AvailablePhone Numbers AvailableCan be contacted by site visitorsHas 3 ArticlesHas special expertise in certain sicknessHas published Books & ArticlesPersonal Info Available
Article Details
* Date : 03-26-2009 - 09:34 PM (5481 days ago),

* Characters : 1844, Words : 252, Size : 1.80 Kb.
In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysis

BACKGROUND: Despite multiple randomized trials demonstrating their efficacy for the secondary prevention of coronary disease, lipid-lowering agents remain underused. Few studies have examined the relationship between predischarge initiation of lipid-lowering therapy and long-term use. METHODS: Using data from patients at 69 centers from the United States and Canada enrolled in the Evaluation in PTCA to Improve Long-term Outcome With Abciximab GP IIb/IIIa Blockade (EPILOG) trial, we performed a retrospective propensity-analyzed cohort study. Patients underwent percutaneous coronary intervention for stable or recently unstable coronary disease and were older than 21 years, were not taking lipid-lowering therapy at the time of admission, and survived to hospital discharge; 175 were discharged taking lipid-lowering therapy and 1951 were not. RESULTS: After 6 months, 77% of patients who started taking lipid-lowering agents before hospital discharge continued taking therapy, compared with only 25% of those discharged without these agents (relative risk, 3.17; 95% confidence interval, 2.88-3.41; P<.001). After restricting the analysis to propensity-matched patients (n = 477) and adjusting for other potential confounders, initiation of a lipid-lowering agent during hospitalization was the strongest independent predictor of use at 6 months (relative risk, 2.50; 95% confidence interval, 2.29-2.65; P<.001). CONCLUSIONS: Inpatient initiation of lipid-lowering therapy is a strong and independent positive predictor of subsequent use, with patients who start taking lipid-lowering therapy before hospital discharge nearly 3 times as likely to be taking these agents 6 months later. Inpatient initiation of lipid-lowering therapy appears to be an effective strategy for bridging the gap between current medical knowledge and practice.

Return to Doctor's Page
Email This Doctor

To Quote this article, you should add: :

All rights of Article "In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysis" belongs to Gian Mendez NOVARO MD and it is published at SuggestADoctor.com (http://www.suggestadoctor.com) Health Articles Library.

With this notice, you can quote reasonable amount of text from this article but you have to get permission from its author to republish or redistribute it fully.

Some other Health Articles from our Library:
  • Facial Plastic Surgery Earns İts Place On ‘most Popular’ Holiday Gift List , Rich CASTELLANO MD
  • Brotox A Phenomenon Popular İn Tampa Bay , Rich CASTELLANO MD
  • Proof Positive, Facial Lifting Procedures Work , Rich CASTELLANO MD
  • Liposuction Is A Treatment For Obesity , Thomas LOCKE MD
  • Weight Loss After Pregnancy , Michele CAVENEE MD
  • Lymphedema — An Overview , Margarita CORREA MD
  • Identification Of A Novel Compound Heterozygous Mutation Of The 5 Alpha-Reductase Type 2 (Srd5a2) Gene İn An Extreme Premature 46, Xy Male İnfant , Cayce JEHAIMI MD
  • "Positron Emission Tomography İn The Management Of Papillary Thyroid Carcinoma İn Children: İs There A Role?" , Cayce JEHAIMI MD
  • "Primary Pigmented Nodular Adrenocortical Disease İn A Patient With Carney Complex: A Case Report" , Cayce JEHAIMI MD
  • "Novel Intervening Sequence Mutation At The 5 , Cayce JEHAIMI MD
  • "Polycystic Ovaries And Adrenal Insufficiency İn A Young Pubescent Female With Lipoid Congenital Adrenal Hyperplasia Due To Splice Mutation Of The Star Gene: A Case Report & Review Of The Literature" , Cayce JEHAIMI MD
  • "Sexual Precocity İn A 2-Year-Old Boy Caused By Indirect Exposure To Testosterone Cream" , Cayce JEHAIMI MD
  • Chemical Addictions , Minh Anh HAN MD
  • Muscle Knot? It Might Be A Trigger Point , Minh Anh HAN MD
  • Cancer Rehabilitation Experience Over Twelve Years. Abstract- Amsterdam, Netherlands 2009 , Susan E CARTER MD
  • Cancer And Exercise. Abstract Brisbane, Australia 2009 , Susan E CARTER MD
  • Is Bacteria Causing You To Feel Bloated Or Have Excessive Flatulence? , Rakesh GUPTA MD
  • Stress And Irritable Bowel Syndrome İn The Real World , Rakesh GUPTA MD
  • Roger Rabbit Medical Mishaps , Mark SARACINO MD
  • Dangerous Herb And Drug Combinations , Mark SARACINO MD
  • All articles published in SuggestADoctor.com is written by Medical Doctors who are also our site members. So although they are considered as depandable resources they should never be used by site visitors without consulting with their own medical doctors, nor should be taken for granted about their being updated or accurate.These articles are for information purposes only and every information they contain must be checked with your own Medical professional.